• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于表征 CAR T 细胞诱导细胞因子风暴的巨噬细胞-内皮细胞界面的体外模型。

An in vitro model of the macrophage-endothelial interface to characterize CAR T-cell induced cytokine storm.

机构信息

Department of Biomedical Engineering, Rutgers University, Piscataway, NJ, USA.

Rutgers Robert Wood Johnson Medical School, Piscataway, NJ, USA.

出版信息

Sci Rep. 2023 Nov 1;13(1):18835. doi: 10.1038/s41598-023-46114-y.

DOI:10.1038/s41598-023-46114-y
PMID:37914765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10620221/
Abstract

Chimeric Antigen Receptor (CAR) T-cell therapy is a highly effective treatment for B-cell malignancies but limited in use due to clinically significant hyperinflammatory toxicities. Understanding the pathophysiologic mechanisms which mediate these toxicities can help identify novel management strategies. Here we report a novel in vitro model of the macrophage-endothelial interface to study the effects of CAR T-cell-induced cytokine storm. Using this model, we demonstrate that macrophage-mediated inflammation is regulated by endothelial cell activity. Furthermore, endothelial inflammation occurs independently of macrophages following exposure to CAR T-cell products and the induced endothelial inflammation potentiates macrophage-mediated inflammatory signaling, leading to a hyperinflammatory environment. While corticosteroids, the current gold standard of care, attenuate the resulting macrophage inflammatory signaling, the endothelial activity remains refractory to this treatment strategy. Utilizing a network model, coupled to in vitro secretion profiling, we identified STAT3 programming as critical in regulating this endothelial behavior. Lastly, we demonstrate how targeting STAT3 activity can abrogate endothelial inflammation and attenuate this otherwise hyperinflammatory environment. Our results demonstrate that endothelial cells play a central role in the pathophysiology of CAR T-cell toxicities and targeting the mechanisms driving the endothelial response can guide future clinical management.

摘要

嵌合抗原受体 (CAR) T 细胞疗法是治疗 B 细胞恶性肿瘤的一种非常有效的方法,但由于其具有临床意义的过度炎症毒性而受到限制。了解介导这些毒性的病理生理机制有助于确定新的治疗策略。在这里,我们报告了一种新型的巨噬细胞-内皮细胞界面体外模型,用于研究 CAR T 细胞诱导的细胞因子风暴的影响。使用该模型,我们证明了巨噬细胞介导的炎症受内皮细胞活性调节。此外,内皮细胞在暴露于 CAR T 细胞产物后会独立于巨噬细胞发生炎症,并且诱导的内皮炎症增强了巨噬细胞介导的炎症信号,导致过度炎症环境。虽然皮质类固醇是目前的标准治疗方法,但可减轻由此产生的巨噬细胞炎症信号,但内皮细胞活性仍然对这种治疗策略具有抗性。利用网络模型,结合体外分泌谱分析,我们确定 STAT3 编程在调节这种内皮行为中起着关键作用。最后,我们证明了如何靶向 STAT3 活性可以阻断内皮炎症并减轻这种过度炎症环境。我们的研究结果表明,内皮细胞在 CAR T 细胞毒性的病理生理学中起着核心作用,针对驱动内皮反应的机制可以指导未来的临床管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/122d/10620221/1a5ae7e133b4/41598_2023_46114_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/122d/10620221/38071d208a4f/41598_2023_46114_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/122d/10620221/b136e94676e8/41598_2023_46114_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/122d/10620221/20d308cbcce9/41598_2023_46114_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/122d/10620221/623a96bf9f9a/41598_2023_46114_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/122d/10620221/ff77cef4b5f7/41598_2023_46114_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/122d/10620221/4bcea805a760/41598_2023_46114_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/122d/10620221/1a5ae7e133b4/41598_2023_46114_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/122d/10620221/38071d208a4f/41598_2023_46114_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/122d/10620221/b136e94676e8/41598_2023_46114_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/122d/10620221/20d308cbcce9/41598_2023_46114_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/122d/10620221/623a96bf9f9a/41598_2023_46114_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/122d/10620221/ff77cef4b5f7/41598_2023_46114_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/122d/10620221/4bcea805a760/41598_2023_46114_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/122d/10620221/1a5ae7e133b4/41598_2023_46114_Fig7_HTML.jpg

相似文献

1
An in vitro model of the macrophage-endothelial interface to characterize CAR T-cell induced cytokine storm.一种用于表征 CAR T 细胞诱导细胞因子风暴的巨噬细胞-内皮细胞界面的体外模型。
Sci Rep. 2023 Nov 1;13(1):18835. doi: 10.1038/s41598-023-46114-y.
2
CAR T-cells and macrophages in large B-cell lymphoma: impact on toxicity and efficacy.嵌合抗原受体 T 细胞和巨噬细胞在弥漫性大 B 细胞淋巴瘤中的作用:对毒性和疗效的影响。
Leuk Lymphoma. 2023 Apr;64(4):808-815. doi: 10.1080/10428194.2023.2185090. Epub 2023 Mar 8.
3
Management of CAR T-cell Related Toxicities: What did the Learning Curve Teach us so Far?嵌合抗原受体 T 细胞相关毒性的管理:迄今为止,学习曲线教会了我们什么?
Hematol Oncol Stem Cell Ther. 2022 Nov 7;15(3):100-111. doi: 10.56875/2589-0646.1029.
4
INSPIRED Symposium Part 3: Prevention and Management of Pediatric Chimeric Antigen Receptor T Cell-Associated Emergent Toxicities.INSPIRED 研讨会第三部分:儿科嵌合抗原受体 T 细胞相关急性毒性的预防和管理。
Transplant Cell Ther. 2024 Jan;30(1):38-55. doi: 10.1016/j.jtct.2023.10.006. Epub 2023 Oct 10.
5
A New Era in Endothelial Injury Syndromes: Toxicity of CAR-T Cells and the Role of Immunity.内皮损伤综合征的新纪元:嵌合抗原受体 T 细胞的毒性和免疫的作用。
Int J Mol Sci. 2020 May 29;21(11):3886. doi: 10.3390/ijms21113886.
6
GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts.GM-CSF 抑制可减少细胞因子释放综合征和神经炎症,但增强异种移植物中的 CAR-T 细胞功能。
Blood. 2019 Feb 14;133(7):697-709. doi: 10.1182/blood-2018-10-881722. Epub 2018 Nov 21.
7
Chimeric Antigen Receptor T-Cell Therapy for the Community Oncologist.社区肿瘤学家的嵌合抗原受体T细胞疗法
Oncologist. 2016 May;21(5):608-17. doi: 10.1634/theoncologist.2015-0421. Epub 2016 Mar 23.
8
Predictive role of endothelial cell activation in cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukaemia.嵌合抗原受体 T 细胞治疗急性淋巴细胞白血病后细胞因子释放综合征中内皮细胞激活的预测作用。
J Cell Mol Med. 2021 Dec;25(24):11063-11074. doi: 10.1111/jcmm.17029. Epub 2021 Nov 3.
9
Extracorporeal cytokine removal in severe CAR-T cell associated cytokine release syndrome.体外细胞因子清除治疗严重 CAR-T 细胞相关细胞因子释放综合征。
J Crit Care. 2020 Jun;57:124-129. doi: 10.1016/j.jcrc.2020.02.010. Epub 2020 Feb 19.
10
Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and management.嵌合抗原受体 T 细胞毒性的最新进展:机制、表现和管理。
Blood Rev. 2019 Mar;34:45-55. doi: 10.1016/j.blre.2018.11.002. Epub 2018 Nov 14.

引用本文的文献

1
New insights into interstitial cystitis/bladder pain syndrome at single-cell resolution.单细胞分辨率下间质性膀胱炎/膀胱疼痛综合征的新见解。
BJUI Compass. 2025 Aug 4;6(8):e70051. doi: 10.1002/bco2.70051. eCollection 2025 Aug.
2
The Potential Use of Digital Twin Technology for Advancing CAR-T Cell Therapy.数字孪生技术在推进嵌合抗原受体T细胞(CAR-T)疗法方面的潜在应用。
Curr Issues Mol Biol. 2025 Apr 30;47(5):321. doi: 10.3390/cimb47050321.
3
Fluvoxamine Inhibited NLRP3 and NF-κB Inflammatory Pathways and Maintained Genital Functions by Ameliorating CD-MPR, KISS-1, AQP4 and Claudin-1 Expressions.

本文引用的文献

1
Successful treatment of severe cytokine release syndrome after CAR-T therapy by ruxolitinib without compromising CAR-T efficacy.鲁索替尼成功治疗CAR-T疗法后严重细胞因子释放综合征且不影响CAR-T疗效。
Leuk Lymphoma. 2023 Feb;64(2):495-498. doi: 10.1080/10428194.2022.2148209. Epub 2022 Nov 17.
2
Ruxolitinib reduces severe CRS response by suspending CAR-T cell function instead of damaging CAR-T cells.芦可替尼通过抑制 CAR-T 细胞的功能而非损伤 CAR-T 细胞来减少严重 CRS 反应。
Biochem Biophys Res Commun. 2022 Mar 5;595:54-61. doi: 10.1016/j.bbrc.2022.01.070. Epub 2022 Jan 20.
3
Blood-Brain Barrier Dysfunction Amplifies the Development of Neuroinflammation: Understanding of Cellular Events in Brain Microvascular Endothelial Cells for Prevention and Treatment of BBB Dysfunction.
氟伏沙明通过改善CD-MPR、KISS-1、水通道蛋白4(AQP4)和闭合蛋白-1(Claudin-1)的表达来抑制NLRP3和NF-κB炎症通路并维持生殖功能。
Basic Clin Pharmacol Toxicol. 2025 Mar;136(3):e70000. doi: 10.1111/bcpt.70000.
4
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR), Growth Differentiation Factor-15 (GDF-15), and Soluble C5b-9 (sC5b-9) Levels Are Significantly Associated with Endothelial Injury Indices in CAR-T Cell Recipients.可溶性尿激酶型纤溶酶原激活物受体 (suPAR)、生长分化因子 15 (GDF-15) 和可溶性 C5b-9 (sC5b-9) 水平与 CAR-T 细胞受者的内皮损伤指标显著相关。
Int J Mol Sci. 2024 Oct 14;25(20):11028. doi: 10.3390/ijms252011028.
5
Mechanisms and management of CAR T toxicity.嵌合抗原受体T细胞毒性的机制与管理
Front Oncol. 2024 May 21;14:1396490. doi: 10.3389/fonc.2024.1396490. eCollection 2024.
6
Case report: Rapid resolution of grade IV ICANS after first line intrathecal chemotherapy with methotrexate, cytarabine and dexamethasone.病例报告:一线鞘内化疗(甲氨蝶呤、阿糖胞苷和地塞米松)后,IV 级 ICANS 迅速缓解。
Front Immunol. 2024 May 3;15:1380451. doi: 10.3389/fimmu.2024.1380451. eCollection 2024.
血脑屏障功能障碍加剧神经炎症的发展:了解脑微血管内皮细胞中的细胞事件以预防和治疗血脑屏障功能障碍。
Front Cell Neurosci. 2021 Sep 13;15:661838. doi: 10.3389/fncel.2021.661838. eCollection 2021.
4
Endothelial SOCS3 maintains homeostasis and promotes survival in endotoxemic mice.内皮细胞 SOCS3 维持内毒素血症小鼠的体内平衡并促进其存活。
JCI Insight. 2021 Jul 22;6(14):e147280. doi: 10.1172/jci.insight.147280.
5
Therapeutic Potential of TNFα and IL1β Blockade for CRS/ICANS in CAR-T Therapy Ameliorating Endothelial Activation.TNFα 和 IL1β 阻断在 CAR-T 治疗中改善内皮细胞激活的 CRS/ICANS 的治疗潜力
Front Immunol. 2021 May 19;12:623610. doi: 10.3389/fimmu.2021.623610. eCollection 2021.
6
Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy.细胞因子释放综合征及癌症免疫治疗相关神经毒性
Nat Rev Immunol. 2022 Feb;22(2):85-96. doi: 10.1038/s41577-021-00547-6. Epub 2021 May 17.
7
CART Cell Toxicities: New Insight into Mechanisms and Management.嵌合抗原受体T细胞(CART)的毒性:对机制与管理的新认识
Clin Hematol Int. 2020 Dec;2(4):149-155. doi: 10.2991/chi.k.201108.001. Epub 2020 Nov 23.
8
Network Analysis Reveals a Distinct Axis of Macrophage Activation in Response to Conflicting Inflammatory Cues.网络分析揭示了在应对冲突性炎症信号时,巨噬细胞激活的一个独特轴。
J Immunol. 2021 Feb 15;206(4):883-891. doi: 10.4049/jimmunol.1901444. Epub 2021 Jan 6.
9
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Encephalitis Is a Cytokine Release Syndrome: Evidences From Cerebrospinal Fluid Analyses.严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)脑炎是一种细胞因子释放综合征:脑脊液分析的证据。
Clin Infect Dis. 2021 Nov 2;73(9):e3019-e3026. doi: 10.1093/cid/ciaa1933.
10
Cytokines in CAR T Cell-Associated Neurotoxicity.嵌合抗原受体 T 细胞相关性神经毒性中的细胞因子。
Front Immunol. 2020 Dec 16;11:577027. doi: 10.3389/fimmu.2020.577027. eCollection 2020.